載入...
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
The advent of immunotherapy, especially checkpoint inhibitor-based immunotherapy, has provided novel and powerful weapons against cancer. Because only a subset of cancer patients exhibit durable responses, further exploration of the mechanisms underlying the resistance to immunotherapy in the bulk o...
Na minha lista:
| 發表在: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389077/ https://ncbi.nlm.nih.gov/pubmed/29482595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0578-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|